Medical Developments International Share Price and Company Fundamentals



Price
$5.23
Change
0.000 (0.000%)
52 week
3.21 - 7.29

Last traded: Last Friday at 6:10 AM

Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company operates through three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management for use in home or in hospitals; Penthrox, a prescription only medicine for pain in trauma; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, resuscitation kits, oxygen therapy masks, and resuscitators. The company also provides veterinary anaesthetic machines, including animal asthma chambers, animal silicone face masks, animal air cushion face masks, resuscitators, MDI tourniquets, vaporisers, animal anaesthetic machines, breathing monitors, autoclavable and disposable CO2 absorbers, and accessories for anaesthetic machines. It operates in Australia, Europe, North America, the Middle East, Asia, and South Africa. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.

Key Metrics

PE ratio

-

PB ratio

5.46

Dividend yield

0.00%

Beta

1.38

Market cap

$372.71M

Enterprise value

$339.49M

Company profile

Primary activitiesPharmaceutical drug business and medical and veterinary equipment business.
Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Full time employees68
Websitehttp://medicaldev.com
Mailing address4 Caribbean Drive Scoresby VIC 3179 Australia
Phone / Fax61 3 9547 1888 / 61 3 9547 0262
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

More: Medical Developments International Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Medical Developments International paid $0.00 dividend and the ex-dividend date was 05 Mar 2020.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MVP dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

MVP's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Medical Developments International.

NameTitleAgeTotal Pay
Mr. Brent MacGregorChief Exec. Officer56540.53k
Mr. Mark Edwards C.A., BAcc, CACFO & Company Sec.246.33k
Matthew CramerChief of Operations & Supply Chain
Thomas MateriaHead of Sales & Marketing
Tara CollierHead of HR
Dr. Scott CourtneyChief Scientific Officer
Michelle BradneyHead of Medical Affairs
Wai Ng ChiHead of Regulatory Affairs
Neil IssaHead of Quality
Wayne PearceHead of Production

Profitability and management effectiveness

Profit margin

-49.72%

Operating margin

-6.41%

Return on assets

-1.09%

Return on equity

-22.51%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Medical Developments International is 372.71M and its enterprise value is 339.49M. The enterprise value to revenue ratio of MVP is 13.43.

The MVP's stocks Beta value is 1.38 making it 38% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Medical Developments International (MVP)

Medical Developments International (ASX:MVP) Frequently Asked Questions

1. What is Medical Developments International's Stock Symbol?

Medical Developments International trades on ASX under the ticker symbol "MVP".

2. What is Medical Developments International's stock price today?

One share of MVP stock can currently be purchased for approximately $5.23.

3. How can I contact Medical Developments International?

Medical Developments International's mailing address is 4 Caribbean Drive Scoresby VIC 3179 Australia. The company can be reached via phone at 61 3 9547 1888.

4. What is Medical Developments International's official website?

The official website of Medical Developments International is http://medicaldev.com.

5. Which share registry manages Medical Developments International's stock?

Medical Developments International's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.